SIMILAR PATTERNS OF AMINO ACIDS FOR 2B7Z_B_MK1B200_2
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1bdm | MALATE DEHYDROGENASE (Thermusthermophilus) |
PF00056(Ldh_1_N)PF02866(Ldh_1_C) | 5 | ALA A 139ILE A 107GLY A 105PRO A 131VAL A 127 | NoneNAX A 334 ( 4.0A)NoneNoneNone | 1.08A | 2b7zB-1bdmA:undetectable | 2b7zB-1bdmA:14.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gvl | KALLIKREIN 6 (Homo sapiens) |
PF00089(Trypsin) | 5 | GLY A 44ALA A 31ILE A 118ILE A 47VAL A 66 | None | 0.84A | 2b7zB-1gvlA:undetectable | 2b7zB-1gvlA:18.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1gz5 | ALPHA-TREHALOSE-PHOSPHATE SYNTHASE (Escherichiacoli) |
PF00982(Glyco_transf_20) | 5 | GLY A 389ALA A 390ILE A 434GLY A 226ILE A 225 | NoneNoneNoneNoneIMD A 902 ( 4.3A) | 0.72A | 2b7zB-1gz5A:undetectable | 2b7zB-1gz5A:15.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ALA A 28ASP A 30ILE A 47GLY A 49ILE A 50PRO A 81 | A79 A 800 (-3.2A)A79 A 800 ( 4.7A)A79 A 800 ( 3.4A)A79 A 800 (-3.4A)A79 A 800 ( 4.0A)A79 A 800 ( 3.4A) | 0.53A | 2b7zB-1hvcA:13.3 | 2b7zB-1hvcA:89.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25ALA A 28ASP A 30ILE A 47GLY A 49ILE A 50 | A79 A 800 (-2.7A)A79 A 800 (-3.1A)A79 A 800 ( 4.9A)A79 A 800 ( 3.2A)A79 A 800 ( 3.7A)A79 A 800 (-3.8A) | 0.54A | 2b7zB-1hvcA:13.3 | 2b7zB-1hvcA:89.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ALA A 22 | A79 A 800 (-2.7A)A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 (-2.8A)A79 A 800 ( 4.9A)None | 1.47A | 2b7zB-1hvcA:13.3 | 2b7zB-1hvcA:89.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ALA A 22 | A79 A 800 (-2.8A)A79 A 800 (-3.0A)A79 A 800 (-3.2A)A79 A 800 (-2.7A)A79 A 800 ( 4.7A)None | 1.40A | 2b7zB-1hvcA:13.3 | 2b7zB-1hvcA:89.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49 | A79 A 800 (-2.7A)A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 (-2.8A)A79 A 800 ( 4.9A)A79 A 800 ( 3.2A)A79 A 800 ( 3.7A) | 0.35A | 2b7zB-1hvcA:13.3 | 2b7zB-1hvcA:89.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49PRO A 81 | A79 A 800 (-2.8A)A79 A 800 (-3.0A)A79 A 800 (-3.2A)A79 A 800 (-2.7A)A79 A 800 ( 4.7A)A79 A 800 ( 3.4A)A79 A 800 (-3.4A)A79 A 800 ( 3.4A) | 0.36A | 2b7zB-1hvcA:13.3 | 2b7zB-1hvcA:89.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1hvc | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ASP A 25GLY A 27ALA A 28ASP A 30ILE A 47GLY A 49PRO A 81 | A79 A 800 (-2.7A)A79 A 800 (-3.0A)A79 A 800 (-3.1A)A79 A 800 ( 4.9A)A79 A 800 ( 3.2A)A79 A 800 ( 3.7A)A79 A 800 ( 3.9A) | 0.50A | 2b7zB-1hvcA:13.3 | 2b7zB-1hvcA:89.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hyl | HYPODERMA LINEATUMCOLLAGENASE (Hypodermalineatum) |
PF00089(Trypsin) | 5 | GLY A 44ALA A 31ILE A 118ILE A 47VAL A 66 | None | 0.83A | 2b7zB-1hylA:undetectable | 2b7zB-1hylA:18.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1n7k | DEOXYRIBOSE-PHOSPHATE ALDOLASE (Aeropyrumpernix) |
PF01791(DeoC) | 5 | ARG A 184GLY A 215ALA A 216ILE A 165ALA A 143 | None | 1.08A | 2b7zB-1n7kA:undetectable | 2b7zB-1n7kA:18.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1obh | LEUCYL-TRNASYNTHETASE (Thermusthermophilus) |
PF00133(tRNA-synt_1)PF08264(Anticodon_1)PF13603(tRNA-synt_1_2)PF14795(Leucyl-specific) | 5 | GLY A 304ALA A 325ASP A 326ALA A 339VAL A 260 | None | 1.01A | 2b7zB-1obhA:2.2 | 2b7zB-1obhA:7.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q9p | HIV-1 PROTEASE (Homo sapiens) |
PF00077(RVP) | 5 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30 | None | 0.38A | 2b7zB-1q9pA:9.9 | 2b7zB-1q9pA:86.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 8 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49PRO A 81 | None | 0.47A | 2b7zB-1sivA:18.9 | 2b7zB-1sivA:51.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1siv | SIV PROTEASE (Simianimmunodeficiencyvirus) |
PF00077(RVP) | 5 | ARG A 8ASP A 30GLY A 49ILE A 50PRO A 81 | None | 0.74A | 2b7zB-1sivA:18.9 | 2b7zB-1sivA:51.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1sqj | OLIGOXYLOGLUCANREDUCING-END-SPECIFIC CELLOBIOHYDROLASE (Geotrichum sp.M128) |
PF15899(BNR_6) | 5 | ARG A 141ASP A 89ASP A 60ILE A 56ILE A 36 | None | 1.05A | 2b7zB-1sqjA:undetectable | 2b7zB-1sqjA:7.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1u11 | PURE(N5-CARBOXYAMINOIMIDAZOLE RIBONUCLEOTIDEMUTASE) (Acetobacteraceti) |
PF00731(AIRC) | 5 | GLY A 85ALA A 84ASP A 33GLY A 136ILE A 135 | CIT A1001 (-4.3A)CIT A1001 (-3.8A)CIT A1001 (-2.9A)NoneNone | 1.04A | 2b7zB-1u11A:undetectable | 2b7zB-1u11A:20.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1x44 | MYOSIN-BINDINGPROTEIN C, SLOW-TYPE (Homo sapiens) |
PF07679(I-set) | 5 | ALA A 36ASP A 35ASP A 34ILE A 57VAL A 31 | None | 0.99A | 2b7zB-1x44A:undetectable | 2b7zB-1x44A:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2aeu | HYPOTHETICAL PROTEINMJ0158 (Methanocaldococcusjannaschii) |
PF03841(SelA) | 5 | ASP A 179GLY A 182ALA A 183ALA A 199VAL A 202 | None | 0.91A | 2b7zB-2aeuA:undetectable | 2b7zB-2aeuA:12.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2dnc | PYRUVATEDEHYDROGENASEPROTEIN X COMPONENT (Homo sapiens) |
PF00364(Biotin_lipoyl) | 5 | ALA A 55ASP A 57ILE A 8ILE A 79VAL A 35 | None | 0.75A | 2b7zB-2dncA:undetectable | 2b7zB-2dncA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2e2n | HEXOKINASE (Sulfurisphaeratokodaii) |
PF01869(BcrAD_BadFG) | 5 | GLY A 29ALA A 16ILE A 48ALA A 60VAL A 5 | None | 1.04A | 2b7zB-2e2nA:undetectable | 2b7zB-2e2nA:16.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2fmb | EQUINE INFECTIOUSANEMIA VIRUSPROTEASE (Equineinfectiousanemia virus) |
PF00077(RVP) | 8 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ILE A 53GLY A 55PRO A 86 | LP1 A 201 (-3.5A)LP1 A 201 (-2.3A)LP1 A 201 (-3.8A)LP1 A 201 (-3.5A)LP1 A 201 (-3.6A)LP1 A 201 (-4.6A)LP1 A 201 (-3.4A)LP1 A 201 (-3.9A) | 0.54A | 2b7zB-2fmbA:15.1 | 2b7zB-2fmbA:27.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2inv | INSULINFRUCTOTRANSFERASE (Bacillus sp.snu-7) |
no annotation | 5 | ASP A 73GLY A 75ALA A 76ASP A 80VAL A 68 | None | 1.08A | 2b7zB-2invA:undetectable | 2b7zB-2invA:14.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2olg | PRO-PHENOLOXIDASEACTIVATING ENZYME-I (Holotrichiadiomphalia) |
PF00089(Trypsin) | 5 | GLY A 142ALA A 125ILE A 236ILE A 145VAL A 171 | None | 0.85A | 2b7zB-2olgA:undetectable | 2b7zB-2olgA:17.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49ILE A 50PRO A 81ALA A 82 | AB1 A 501 ( 4.7A)AB1 A 501 (-2.4A)AB1 A 501 (-3.9A)AB1 A 501 (-3.5A)AB1 A 501 ( 3.3A)AB1 A 501 (-3.8A)AB1 A 501 (-3.5A)AB1 A 501 (-3.8A)AB1 A 501 (-4.2A)AB1 A 501 (-3.6A) | 0.44A | 2b7zB-2rkfA:20.7 | 2b7zB-2rkfA:85.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rkf | PROTEASE RETROPEPSIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ALA A 22 | AB1 A 501 (-2.4A)AB1 A 501 (-3.9A)AB1 A 501 (-3.5A)AB1 A 501 ( 3.3A)AB1 A 501 (-3.8A)None | 1.32A | 2b7zB-2rkfA:20.7 | 2b7zB-2rkfA:85.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2rsp | RSV PROTEASE (Rous sarcomavirus) |
PF00077(RVP) | 5 | ARG A 10ASP A 37GLY A 39ALA A 40ASP A 41 | None | 0.76A | 2b7zB-2rspA:12.8 | 2b7zB-2rspA:32.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vn8 | RETICULON-4-INTERACTING PROTEIN 1 (Homo sapiens) |
PF08240(ADH_N)PF13602(ADH_zinc_N_2) | 5 | GLY A 248ALA A 249ASP A 250ASP A 251ALA A 240 | None | 1.05A | 2b7zB-2vn8A:undetectable | 2b7zB-2vn8A:19.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2w3y | VIRULENCE FACTOR (Pectobacteriumcarotovorum) |
no annotation | 5 | ASP A 244ILE A 230GLY A 63ILE A 65VAL A 243 | None | 0.91A | 2b7zB-2w3yA:undetectable | 2b7zB-2w3yA:17.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2z1u | HYDROGENASEEXPRESSION/FORMATIONPROTEIN HYPE (Desulfovibriovulgaris) |
PF00586(AIRS)PF02769(AIRS_C) | 5 | GLY A 233ALA A 232ILE A 275ALA A 225VAL A 317 | None | 1.06A | 2b7zB-2z1uA:undetectable | 2b7zB-2z1uA:14.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3c6m | SPERMINE SYNTHASE (Homo sapiens) |
PF01564(Spermine_synth)PF17284(Spermine_synt_N) | 5 | ARG A 268ILE A 221GLY A 198ILE A 196VAL A 259 | NoneMTA A 401 (-3.8A)MTA A 401 (-3.3A)NoneNone | 1.04A | 2b7zB-3c6mA:undetectable | 2b7zB-3c6mA:15.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3emy | TRICHODERMA REESEIASPARTIC PROTEASE (Trichodermareesei) |
PF00026(Asp) | 5 | GLY A 298ASP A 224ILE A 207GLY A 212ILE A 213 | None | 0.88A | 2b7zB-3emyA:6.6 | 2b7zB-3emyA:16.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3fv3 | SAPP1P-SECRETEDASPARTIC PROTEASE 1 (Candidaparapsilosis) |
PF00026(Asp) | 5 | ASP A 220GLY A 222GLY A 119ILE A 120ALA A 196 | None | 0.95A | 2b7zB-3fv3A:7.7 | 2b7zB-3fv3A:12.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gi8 | UNCHARACTERIZEDPROTEIN MJ0609 (Methanocaldococcusjannaschii) |
PF13520(AA_permease_2) | 5 | GLY C 279ALA C 280GLY C 23ILE C 22ALA C 259 | None | 1.03A | 2b7zB-3gi8C:undetectable | 2b7zB-3gi8C:12.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3gt7 | SENSOR PROTEIN (Syntrophusaciditrophicus) |
PF00072(Response_reg) | 5 | ARG A 102GLY A 107ALA A 108ASP A 109ILE A 59 | None | 0.98A | 2b7zB-3gt7A:undetectable | 2b7zB-3gt7A:22.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3kf3 | INVERTASE (Schwanniomycesoccidentalis) |
PF00251(Glyco_hydro_32N)PF08244(Glyco_hydro_32C) | 5 | ASP A 287GLY A 289ASP A 291ILE A 485PRO A 355 | NoneNoneNoneNoneNAG A5001 ( 4.9A) | 0.93A | 2b7zB-3kf3A:undetectable | 2b7zB-3kf3A:12.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lez | BETA-LACTAMASE (Oceanobacillusiheyensis) |
PF13354(Beta-lactamase2) | 5 | ALA A 64GLY A 260ILE A 259ALA A 294VAL A 298 | None | 0.97A | 2b7zB-3lezA:undetectable | 2b7zB-3lezA:19.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lez | BETA-LACTAMASE (Oceanobacillusiheyensis) |
PF13354(Beta-lactamase2) | 5 | ALA A 64ILE A 262GLY A 260ILE A 259ALA A 294 | None | 0.81A | 2b7zB-3lezA:undetectable | 2b7zB-3lezA:19.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3lp6 | PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASECATALYTIC SUBUNIT (Mycobacteriumtuberculosis) |
PF00731(AIRC) | 5 | GLY A 71ALA A 70ASP A 19GLY A 122ILE A 121 | FMT A 175 (-4.1A)FMT A 175 ( 4.3A)FMT A 175 (-3.5A)NoneNone | 0.97A | 2b7zB-3lp6A:undetectable | 2b7zB-3lp6A:18.29 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | ALA A 28ASP A 29ASP A 30GLY A 48PRO A 81 | None | 0.88A | 2b7zB-3mwsA:19.8 | 2b7zB-3mwsA:74.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47PRO A 81 | None | 0.55A | 2b7zB-3mwsA:19.8 | 2b7zB-3mwsA:74.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 9 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ILE A 47GLY A 49ILE A 50PRO A 81 | None | 0.53A | 2b7zB-3mwsA:19.8 | 2b7zB-3mwsA:74.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3mws | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ALA A 22 | None | 1.31A | 2b7zB-3mwsA:19.8 | 2b7zB-3mwsA:74.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3opq | PHOSPHORIBOSYLAMINOIMIDAZOLECARBOXYLASE,CATALYTIC SUBUNIT (Francisellatularensis) |
PF00731(AIRC) | 5 | GLY A 66ALA A 65ASP A 14GLY A 117ILE A 116 | PO4 A 164 (-3.7A)PO4 A 164 (-3.3A)PO4 A 164 (-2.8A)FMT A 166 (-3.3A)None | 1.00A | 2b7zB-3opqA:undetectable | 2b7zB-3opqA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3q9t | CHOLINEDEHYDROGENASE ANDRELATEDFLAVOPROTEINS (Aspergillusoryzae) |
PF00732(GMC_oxred_N)PF05199(GMC_oxred_C) | 5 | GLY A 280ASP A 297GLY A 537ALA A 518VAL A 301 | None | 1.06A | 2b7zB-3q9tA:undetectable | 2b7zB-3q9tA:11.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3qlj | SHORT CHAINDEHYDROGENASE (Mycobacteriumavium) |
PF00106(adh_short) | 5 | GLY A 102ALA A 101ILE A 178ALA A 130VAL A 74 | CL A 302 (-3.6A)NoneNoneNoneNone | 0.92A | 2b7zB-3qljA:undetectable | 2b7zB-3qljA:14.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sn0 | PUTATIVEL-ALANINE-DL-GLUTAMATE EPIMERASE (Paraburkholderiaxenovorans) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | ARG A 273GLY A 80ASP A 290GLY A 87ILE A 86 | None | 0.83A | 2b7zB-3sn0A:undetectable | 2b7zB-3sn0A:12.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49PRO A 81ALA A 82VAL A 84 | 017 A 201 (-3.5A)017 A 201 (-3.5A)017 A 201 (-4.2A)None017 A 201 (-4.0A)NoneSO4 A 101 (-3.5A)None | 0.62A | 2b7zB-3t3cA:18.9 | 2b7zB-3t3cA:77.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | ARG A 8ASP A 29ILE A 47GLY A 49ILE A 50 | SO4 A 101 (-3.8A)017 A 201 (-3.5A)None017 A 201 (-4.0A)017 A 201 (-3.3A) | 0.71A | 2b7zB-3t3cA:18.9 | 2b7zB-3t3cA:77.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3t3c | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 10 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49ILE A 50ALA A 82VAL A 84 | 017 A 201 (-2.6A)017 A 201 (-3.4A)017 A 201 (-3.5A)017 A 201 (-3.5A)017 A 201 (-4.2A)None017 A 201 (-4.0A)017 A 201 (-3.3A)SO4 A 101 (-3.5A)None | 0.49A | 2b7zB-3t3cA:18.9 | 2b7zB-3t3cA:77.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3trh | PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASECARBOXYLTRANSFERASESUBUNIT (Coxiellaburnetii) |
PF00731(AIRC) | 5 | GLY A 67ALA A 66ASP A 15GLY A 118ILE A 117 | None | 1.04A | 2b7zB-3trhA:undetectable | 2b7zB-3trhA:20.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 50PRO A 81 | 017 A 201 ( 4.8A)017 A 201 (-2.6A)017 A 201 (-3.6A)017 A 201 (-3.4A)017 A 201 (-3.3A)017 A 201 (-4.6A)017 A 201 (-3.3A)017 A 201 (-4.1A) | 0.46A | 2b7zB-3ttpA:20.3 | 2b7zB-3ttpA:81.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 8 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29GLY A 49ILE A 50PRO A 81 | 017 A 201 ( 4.8A)017 A 201 (-2.6A)017 A 201 (-3.6A)017 A 201 (-3.4A)017 A 201 (-3.3A)017 A 201 (-3.0A)017 A 201 (-3.3A)017 A 201 (-4.1A) | 0.41A | 2b7zB-3ttpA:20.3 | 2b7zB-3ttpA:81.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ttp | HIV-1 PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ALA A 22 | 017 A 201 (-2.6A)017 A 201 (-3.6A)017 A 201 (-3.4A)017 A 201 (-3.3A)017 A 201 (-4.6A)None | 1.32A | 2b7zB-3ttpA:20.3 | 2b7zB-3ttpA:81.82 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3u7s | POL POLYPROTEIN (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 11 | ARG A 8ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49ILE A 50PRO A 81VAL A 84 | None017 A 202 ( 2.5A)017 A 201 ( 3.5A)017 A 201 (-3.4A)017 A 201 (-3.2A)017 A 201 ( 4.0A)017 A 202 (-3.6A)017 A 202 (-2.9A)017 A 201 ( 3.5A)017 A 202 (-4.0A)None | 0.55A | 2b7zB-3u7sA:20.2 | 2b7zB-3u7sA:83.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3uhl | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ALA A 28ASP A 29PRO A 81VAL A 84 | None | 0.55A | 2b7zB-3uhlA:16.5 | 2b7zB-3uhlA:81.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3w2i | NADH-CYTOCHROME B5REDUCTASE 3 (Sus scrofa) |
PF00175(NAD_binding_1)PF00970(FAD_binding_6) | 5 | ASP A 72ASP A 73GLY A 43ILE A 5PRO A 36 | None | 0.99A | 2b7zB-3w2iA:undetectable | 2b7zB-3w2iA:17.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wuf | ENDO-1,4-BETA-XYLANASE A (Streptomycessp.) |
PF00331(Glyco_hydro_10) | 5 | ASP A 291GLY A 247ALA A 246PRO A 341ALA A 342 | None | 1.06A | 2b7zB-3wufA:undetectable | 2b7zB-3wufA:14.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ad8 | DNA REPAIR PROTEINRECN (Deinococcusradiodurans) |
PF02463(SMC_N) | 5 | ASP A 474ASP A 471ILE A 70GLY A 66ALA A 508 | None | 0.82A | 2b7zB-4ad8A:undetectable | 2b7zB-4ad8A:9.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4c75 | BETA-LACTAMASE (syntheticconstruct) |
PF13354(Beta-lactamase2) | 5 | ALA A 48ILE A 250ILE A 247ALA A 282VAL A 286 | None | 0.98A | 2b7zB-4c75A:undetectable | 2b7zB-4c75A:15.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4emi | TODA (Pseudomonasputida) |
PF07992(Pyr_redox_2)PF14759(Reductase_C) | 5 | ARG A 226ILE A 235ILE A 171ALA A 222VAL A 220 | None | 0.98A | 2b7zB-4emiA:undetectable | 2b7zB-4emiA:14.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g1u | HEMIN TRANSPORTSYSTEM PERMEASEPROTEIN HMUU (Yersinia pestis) |
PF01032(FecCD) | 5 | GLY A 126ALA A 96GLY A 101ILE A 103VAL A 251 | None | 1.03A | 2b7zB-4g1uA:undetectable | 2b7zB-4g1uA:14.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4g5e | 2,4,6-TRICHLOROPHENOL 4-MONOOXYGENASE (Cupriaviduspinatubonensis) |
PF03241(HpaB)PF11794(HpaB_N) | 5 | GLY A 126ALA A 127ILE A 183ILE A 216VAL A 131 | None | 0.85A | 2b7zB-4g5eA:undetectable | 2b7zB-4g5eA:14.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4grd | PHOSPHORIBOSYLAMINOIMIDAZOLE CARBOXYLASECATALYTIC SUBUNIT (Burkholderiacenocepacia) |
PF00731(AIRC) | 5 | GLY A 77ALA A 76ASP A 25GLY A 128ILE A 127 | None | 0.99A | 2b7zB-4grdA:undetectable | 2b7zB-4grdA:18.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hdj | OUTER MEMBRANEPROTEIN ASSEMBLYFACTOR BAMB (Pseudomonasaeruginosa) |
PF13360(PQQ_2) | 5 | ASP A 207GLY A 160ILE A 159PRO A 187ALA A 196 | None | 0.69A | 2b7zB-4hdjA:undetectable | 2b7zB-4hdjA:14.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ida | RIPENING-INDUCEDPROTEIN (Fragaria vesca) |
PF08240(ADH_N)PF13602(ADH_zinc_N_2) | 5 | GLY A 208ALA A 209ASP A 210ILE A 179ALA A 196 | NoneNoneNoneNoneSO4 A 402 (-3.3A) | 0.94A | 2b7zB-4idaA:undetectable | 2b7zB-4idaA:16.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j0k | TANNASE (Lactobacillusplantarum) |
no annotation | 5 | GLY A 416ASP A 421ILE A 206ILE A 413ALA A 425 | NoneEGR A 501 (-3.5A)EGR A 501 (-4.0A)NoneNone | 1.04A | 2b7zB-4j0kA:undetectable | 2b7zB-4j0kA:13.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jyj | ENOYL-COAHYDRATASE/ISOMERASE (Novosphingobiumaromaticivorans) |
PF00378(ECH_1) | 5 | GLY A 107ALA A 129ASP A 168ILE A 167VAL A 125 | None | 0.99A | 2b7zB-4jyjA:undetectable | 2b7zB-4jyjA:18.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4jyj | ENOYL-COAHYDRATASE/ISOMERASE (Novosphingobiumaromaticivorans) |
PF00378(ECH_1) | 5 | GLY A 107ALA A 129ILE A 167ILE A 110ALA A 117 | None | 0.87A | 2b7zB-4jyjA:undetectable | 2b7zB-4jyjA:18.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k3w | ENOYL-COAHYDRATASE/ISOMERASE (Marinobacterhydrocarbonoclasticus) |
PF00378(ECH_1) | 5 | GLY A 117ALA A 139ASP A 179ILE A 178GLY A 142 | None | 1.03A | 2b7zB-4k3wA:undetectable | 2b7zB-4k3wA:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4k48 | LEUCINE--TRNA LIGASE (Streptococcuspneumoniae) |
PF13603(tRNA-synt_1_2) | 5 | GLY A 304ALA A 325ASP A 326ALA A 339VAL A 260 | None | 1.00A | 2b7zB-4k48A:2.4 | 2b7zB-4k48A:19.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m98 | PILIN GLYCOSYLATIONPROTEIN (Neisseriagonorrhoeae) |
PF00132(Hexapep) | 5 | GLY A 206ALA A 264ILE A 261ALA A 218VAL A 214 | None | 0.88A | 2b7zB-4m98A:undetectable | 2b7zB-4m98A:19.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4m9a | ACYL-COADEHYDROGENASE (Burkholderiathailandensis) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 5 | GLY A 152GLY A 192ILE A 194ALA A 166VAL A 168 | None | 0.93A | 2b7zB-4m9aA:undetectable | 2b7zB-4m9aA:14.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4n5f | PUTATIVE ACYL-COADEHYDROGENASE (Burkholderiacenocepacia) |
PF00441(Acyl-CoA_dh_1)PF02770(Acyl-CoA_dh_M)PF02771(Acyl-CoA_dh_N) | 5 | GLY A 152GLY A 192ILE A 194ALA A 166VAL A 168 | None | 1.00A | 2b7zB-4n5fA:undetectable | 2b7zB-4n5fA:15.02 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ALA A 22 | RIT A 500 (-2.4A)RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 (-4.8A)None | 1.35A | 2b7zB-4njvA:20.1 | 2b7zB-4njvA:84.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30PRO A 81 | RIT A 500 (-2.4A)RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 (-4.8A)RIT A 500 (-3.9A) | 0.48A | 2b7zB-4njvA:20.1 | 2b7zB-4njvA:84.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ASP A 25GLY A 27ALA A 28ASP A 29ILE A 47GLY A 49PRO A 81 | RIT A 500 (-2.4A)RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 (-3.2A)RIT A 500 ( 4.5A)RIT A 500 (-3.4A)RIT A 500 (-3.9A) | 0.38A | 2b7zB-4njvA:20.1 | 2b7zB-4njvA:84.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4njv | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ASP A 25GLY A 27ALA A 28ILE A 47GLY A 49ILE A 50PRO A 81 | RIT A 500 (-2.4A)RIT A 500 (-3.9A)RIT A 500 (-3.6A)RIT A 500 ( 4.5A)RIT A 500 (-3.4A)RIT A 500 (-4.3A)RIT A 500 (-3.9A) | 0.45A | 2b7zB-4njvA:20.1 | 2b7zB-4njvA:84.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4q98 | MAJOR FIMBRIALSUBUNIT PROTEIN (Porphyromonasgingivalis) |
PF06321(P_gingi_FimA)PF15495(Fimbrillin_C) | 5 | GLY A 261ALA A 260GLY A 181PRO A 198ALA A 201 | None | 0.80A | 2b7zB-4q98A:undetectable | 2b7zB-4q98A:15.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qpb | LYSOSTAPHIN (Staphylococcussimulans) |
PF01551(Peptidase_M23) | 5 | GLY A 344ALA A 294ILE A 314GLY A 348VAL A 341 | None | 0.95A | 2b7zB-4qpbA:undetectable | 2b7zB-4qpbA:24.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4qsl | PYRUVATE CARBOXYLASE (Listeriamonocytogenes) |
no annotation | 5 | GLY H 77ALA H 78ASP H 79ILE H 28ALA H 32 | None | 0.88A | 2b7zB-4qslH:undetectable | 2b7zB-4qslH:6.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ra7 | PEPTIDOGLYCANGLYCOSYLTRANSFERASE (Atopobiumparvulum) |
PF00905(Transpeptidase) | 5 | GLY A 933ALA A 934ILE A 887GLY A 907ILE A 906 | None | 0.77A | 2b7zB-4ra7A:undetectable | 2b7zB-4ra7A:12.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rk9 | CARBOHYDRATE ABCTRANSPORTERSUBSTRATE-BINDINGPROTEIN MSME (Bacilluslicheniformis) |
PF01547(SBP_bac_1) | 5 | ILE A 303GLY A 143ILE A 144PRO A 300ALA A 293 | None | 1.02A | 2b7zB-4rk9A:undetectable | 2b7zB-4rk9A:20.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4wzz | PUTATIVE SUGAR ABCTRANSPORTER,SUBSTRATE-BINDINGPROTEIN (Lachnoclostridiumphytofermentans) |
PF13407(Peripla_BP_4) | 5 | ASP A 342GLY A 344ALA A 340ILE A 348ALA A 191 | EDO A 402 ( 4.2A)NoneNoneNoneEDO A 402 ( 3.6A) | 0.98A | 2b7zB-4wzzA:undetectable | 2b7zB-4wzzA:14.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ydf | HTLV-1 PROTEASE (PrimateT-lymphotropicvirus 1) |
PF00077(RVP) | 6 | ARG A 10ASP A 32GLY A 34ALA A 35ASP A 36GLY A 58 | None4B1 A 201 (-2.9A)4B1 A 201 ( 4.6A)4B1 A 201 (-3.6A)4B1 A 201 (-4.4A)4B1 A 201 (-3.4A) | 0.54A | 2b7zB-4ydfA:12.6 | 2b7zB-4ydfA:28.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b18 | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | ARG A 8GLY A 27ALA A 28ASP A 29ASP A 30 | None | 0.44A | 2b7zB-5b18A:18.2 | 2b7zB-5b18A:79.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b18 | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 5 | GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49 | None | 0.67A | 2b7zB-5b18A:18.2 | 2b7zB-5b18A:79.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5bsw | 4-COUMARATE--COALIGASE 2 (Nicotianatabacum) |
PF00501(AMP-binding)PF13193(AMP-binding_C) | 5 | GLY A 101ALA A 102ASP A 78ILE A 173ALA A 93 | None | 1.06A | 2b7zB-5bswA:undetectable | 2b7zB-5bswA:11.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5evj | ARSENITEMETHYLTRANSFERASE (Chlamydomonasreinhardtii) |
PF13847(Methyltransf_31) | 5 | GLY A 223ALA A 224GLY A 218ALA A 264VAL A 202 | None | 0.83A | 2b7zB-5evjA:undetectable | 2b7zB-5evjA:14.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5g4x | SH3 AND MULTIPLEANKYRIN REPEATDOMAINS PROTEIN 3 (Rattusnorvegicus) |
PF12796(Ank_2)PF16511(FERM_f0) | 5 | GLY A 206ALA A 207ASP A 177ALA A 190VAL A 187 | NoneNoneEDO A1357 (-2.8A)NoneNone | 1.03A | 2b7zB-5g4xA:undetectable | 2b7zB-5g4xA:14.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jho | ELECTRONEUTRALSODIUM BICARBONATEEXCHANGER 1 (Homo sapiens) |
PF07565(Band_3_cyto) | 5 | GLY A 253ASP A 68GLY A 304ILE A 303ALA A 264 | None | 0.97A | 2b7zB-5jhoA:undetectable | 2b7zB-5jhoA:16.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5t2z | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 7 | ARG A 8ASP A 25GLY A 27ALA A 28GLY A 49ILE A 50PRO A 81 | None | 0.54A | 2b7zB-5t2zA:20.9 | 2b7zB-5t2zA:82.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5t2z | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 6 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ALA A 22 | None | 1.31A | 2b7zB-5t2zA:20.9 | 2b7zB-5t2zA:82.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5t2z | PROTEASE (Humanimmunodeficiencyvirus 1) |
PF00077(RVP) | 9 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30ILE A 47GLY A 49ILE A 50PRO A 81 | None | 0.49A | 2b7zB-5t2zA:20.9 | 2b7zB-5t2zA:82.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5tfq | BETA-LACTAMASE (Bacteroidescellulosilyticus) |
PF13354(Beta-lactamase2) | 5 | GLY A 234ALA A 233ASP A 232ILE A 109VAL A 167 | None | 0.81A | 2b7zB-5tfqA:undetectable | 2b7zB-5tfqA:15.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w1a | MYOSIN HEAVY CHAIN,MUSCLE (Drosophilamelanogaster) |
no annotation | 5 | ALA A 260ASP A 261GLY A 457ILE A 456VAL A 219 | None | 0.97A | 2b7zB-5w1aA:undetectable | 2b7zB-5w1aA:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fiv | RETROPEPSIN (Felineimmunodeficiencyvirus) |
PF00077(RVP) | 6 | ARG A 13ASP A 30GLY A 32ALA A 33ASP A 34GLY A 58 | None3TL A 201 (-3.5A)3TL A 201 (-3.4A)3TL A 201 (-4.0A)3TL A 201 (-3.9A)3TL A 201 (-3.4A) | 0.41A | 2b7zB-6fivA:15.8 | 2b7zB-6fivA:27.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6upj | HIV-2 PROTEASE (Humanimmunodeficiencyvirus 2) |
PF00077(RVP) | 5 | ARG A 8ASP A 25GLY A 49ILE A 50PRO A 81 | NoneNIU A 100 (-2.8A)NIU A 100 ( 3.8A)NIU A 100 (-3.9A)None | 0.70A | 2b7zB-6upjA:18.5 | 2b7zB-6upjA:50.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6upj | HIV-2 PROTEASE (Humanimmunodeficiencyvirus 2) |
PF00077(RVP) | 8 | ASP A 25GLY A 27ALA A 28ASP A 29ASP A 30GLY A 49ILE A 50PRO A 81 | NIU A 100 (-2.8A)NIU A 100 (-4.5A)NIU A 100 (-3.6A)NoneNoneNIU A 100 ( 3.8A)NIU A 100 (-3.9A)None | 0.63A | 2b7zB-6upjA:18.5 | 2b7zB-6upjA:50.51 |